UniProt ID | BIRC5_HUMAN | |
---|---|---|
UniProt AC | O15392 | |
Protein Name | Baculoviral IAP repeat-containing protein 5 | |
Gene Name | BIRC5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 142 | |
Subcellular Localization | Cytoplasm . Nucleus . Chromosome . Chromosome, centromere . Cytoplasm, cytoskeleton, spindle . Chromosome, centromere, kinetochore . Midbody . Localizes at the centromeres from prophase to metaphase, at the spindle midzone during anaphase and a the m | |
Protein Description | Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis. [PubMed: 9859993] | |
Protein Sequence | MGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Ubiquitination | PAWQPFLKDHRISTF CCCHHHHCCCCCCCC | 52.44 | - | |
20 | Phosphorylation | FLKDHRISTFKNWPF HHCCCCCCCCCCCCC | 27.96 | 20427271 | |
21 | Phosphorylation | LKDHRISTFKNWPFL HCCCCCCCCCCCCCC | 35.94 | 20427271 | |
23 | Acetylation | DHRISTFKNWPFLEG CCCCCCCCCCCCCCC | 59.18 | 20826784 | |
23 | Ubiquitination | DHRISTFKNWPFLEG CCCCCCCCCCCCCCC | 59.18 | PubMed | |
34 | Phosphorylation | FLEGCACTPERMAEA CCCCCCCCHHHHHHC | 15.06 | 25159151 | |
48 | Phosphorylation | AGFIHCPTENEPDLA CCCEECCCCCCCCHH | 57.76 | 21252625 | |
62 | Ubiquitination | AQCFFCFKELEGWEP HHHHHHHHHHCCCCC | 63.67 | PubMed | |
78 (in isoform 5) | Ubiquitination | - | 56.30 | 21906983 | |
78 (in isoform 4) | Ubiquitination | - | 56.30 | 21906983 | |
78 (in isoform 1) | Ubiquitination | - | 56.30 | 21906983 | |
78 | Ubiquitination | DDPIEEHKKHSSGCA CCHHHHHHHHCCCCE | 56.30 | PubMed | |
78 | Acetylation | DDPIEEHKKHSSGCA CCHHHHHHHHCCCCE | 56.30 | 26051181 | |
79 | Ubiquitination | DPIEEHKKHSSGCAF CHHHHHHHHCCCCEE | 51.10 | PubMed | |
82 | Phosphorylation | EEHKKHSSGCAFLSV HHHHHHCCCCEEHHH | 37.30 | 29214152 | |
90 | Ubiquitination | GCAFLSVKKQFEELT CCEEHHHHHHHHHCC | 37.16 | - | |
90 | Acetylation | GCAFLSVKKQFEELT CCEEHHHHHHHHHCC | 37.16 | 20826784 | |
91 | Ubiquitination | CAFLSVKKQFEELTL CEEHHHHHHHHHCCH | 59.05 | - | |
103 | Ubiquitination | LTLGEFLKLDRERAK CCHHHHHHHHHHHHH | 54.37 | - | |
110 | Acetylation | KLDRERAKNKIAKET HHHHHHHHHHHHHHH | 66.06 | 20826784 | |
112 | Acetylation | DRERAKNKIAKETNN HHHHHHHHHHHHHHH | 43.25 | 20826784 | |
113 | Acetylation | RERAKNKIAKETNNK HHHHHHHHHHHHHHH | 10.40 | 20826784 | |
113 | Ubiquitination | RERAKNKIAKETNNK HHHHHHHHHHHHHHH | 10.40 | 20826784 | |
114 | Ubiquitination | ERAKNKIAKETNNKK HHHHHHHHHHHHHHH | 12.77 | - | |
115 | Acetylation | RAKNKIAKETNNKKK HHHHHHHHHHHHHHH | 69.42 | 20826784 | |
117 | Phosphorylation | KNKIAKETNNKKKEF HHHHHHHHHHHHHHH | 43.30 | 14610074 | |
120 | Acetylation | IAKETNNKKKEFEET HHHHHHHHHHHHHHH | 68.26 | 20826784 | |
121 | Acetylation | AKETNNKKKEFEETA HHHHHHHHHHHHHHH | 60.71 | 20826784 | |
122 | Acetylation | KETNNKKKEFEETAK HHHHHHHHHHHHHHH | 70.06 | 20826784 | |
126 | Ubiquitination | NKKKEFEETAKKVRR HHHHHHHHHHHHHHH | 60.43 | - | |
129 | Acetylation | KEFEETAKKVRRAIE HHHHHHHHHHHHHHH | 60.26 | 20826784 | |
130 | Acetylation | EFEETAKKVRRAIEQ HHHHHHHHHHHHHHH | 38.21 | 20826784 | |
133 | Acetylation | ETAKKVRRAIEQLAA HHHHHHHHHHHHHHC | 42.79 | 20826784 | |
135 | Acetylation | AKKVRRAIEQLAAMD HHHHHHHHHHHHCCC | 3.08 | 20826784 | |
138 | Acetylation | VRRAIEQLAAMD--- HHHHHHHHHCCC--- | 1.81 | 20826784 | |
140 | Phosphorylation | RAIEQLAAMD----- HHHHHHHCCC----- | 15.98 | 14610074 | |
143 | Acetylation | EQLAAMD-------- HHHHCCC-------- | - | ||
144 | Acetylation | QLAAMD--------- HHHCCC--------- | 20826784 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
20 | S | Phosphorylation | Kinase | AURC | Q9UQB9 | PSP |
20 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
20 | S | Phosphorylation | Kinase | PRKACA | P27791 | GPS |
20 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
21 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
34 | T | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
34 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
34 | T | Phosphorylation | Kinase | CDK15 | Q96Q40 | Uniprot |
48 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
48 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
48 | T | Phosphorylation | Kinase | CK2 | - | Uniprot |
117 | T | Phosphorylation | Kinase | AURB | Q96GD4 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXL7 | Q9UJT9 | PMID:25778398 |
- | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:17613533 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
120 | Acetylation | 129 (9) | E ⇒ K | rs2071214 |
| 23942779 |
121 | Acetylation | 129 (8) | E ⇒ K | rs2071214 |
| 23942779 |
122 | Acetylation | 129 (7) | E ⇒ K | rs2071214 |
| 23942779 |
129 | Acetylation | 129 (0) | E ⇒ K | rs2071214 |
| 23942779 |
130 | Acetylation | 129 (1) | E ⇒ K | rs2071214 |
| 23942779 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Acetylation directs survivin nuclear localization to repress STAT3oncogenic activity."; Wang H., Holloway M.P., Ma L., Cooper Z.A., Riolo M., Samkari A.,Elenitoba-Johnson K.S., Chin Y.E., Altura R.A.; J. Biol. Chem. 285:36129-36137(2010). Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH STAT3 AND XPO1/CRM1,ACETYLATION AT LYS-23; LYS-90; LYS-110; LYS-112; LYS-115; LYS-121 ANDLYS-129, MUTAGENESIS OF LYS-129, AND CHARACTERIZATION OF VARIANTGLU-129. | |
Phosphorylation | |
Reference | PubMed |
"Threonine 48 in the BIR domain of survivin is critical to its mitoticand anti-apoptotic activities and can be phosphorylated by CK2 invitro."; Barrett R.M., Colnaghi R., Wheatley S.P.; Cell Cycle 10:538-548(2011). Cited for: PHOSPHORYLATION AT THR-48, AND MUTAGENESIS OF THR-48. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34, AND MASSSPECTROMETRY. | |
"Aurora-B phosphorylation in vitro identifies a residue of survivinthat is essential for its localization and binding to inner centromereprotein (INCENP) in vivo."; Wheatley S.P., Henzing A.J., Dodson H., Khaled W., Earnshaw W.C.; J. Biol. Chem. 279:5655-5660(2004). Cited for: INTERACTION WITH INCENP, SUBCELLULAR LOCATION, PHOSPHORYLATION ATTHR-117, AND MUTAGENESIS OF THR-117. | |
"Regulation of apoptosis at cell division by p34cdc2 phosphorylationof survivin."; O'Connor D.S., Grossman D., Plescia J., Li F., Zhang H., Villa A.,Tognin S., Marchisio P.C., Altieri D.C.; Proc. Natl. Acad. Sci. U.S.A. 97:13103-13107(2000). Cited for: PHOSPHORYLATION AT THR-34. |